Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
321 results
  • Naratriptan in the Prophylactic Treatment of Cluster Headache. [Journal Article]
  • IMIntern Med 2017 Oct 01; 56(19):2579-2582
  • Ito Y, Mitsufuji T, … Araki N
  • Objective Naratriptan has been reported to reduce the frequency of cluster headache. The purpose of this study was to determine whether naratriptan is effective as a prophylactic treatment for cluste...
  • Triptan use in Australia 1997-2015: A pharmacoepidemiological study. [Journal Article]
  • ANActa Neurol Scand 2017; 136(2):155-159
  • Eyre BLKD, Eadie MJ, … Hollingworth SA
  • CONCLUSIONS: The use of triptan derivatives in Australia per head of population for treating migraine attacks continued to increase over the 18-year period studied, with use of recently introduced derivatives more than substituting for decreased use of older triptans. This suggests that the available treatments of migraine attacks had achieved what were considered less than adequate therapeutic outcomes.
  • Menstrual Migraine and Treatment Options: Review. [Review]
  • HHeadache 2017; 57(2):194-208
  • Maasumi K, Tepper SJ, Kriegler JS
  • CONCLUSIONS: MM can be very difficult to treat. For acute treatments, rizatriptan has the best overall evidence. For short-term prevention, frovatriptan, zolmitriptan, or naratriptan, as well as magnesium, estrogen, naproxen sodium, or dihydroergotamine may be useful.
New Search Next